Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)

17Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Bravecto™ (fluralaner; MSD Animal Health) is a novel systemic ectoparasiticide for dogs providing long-acting flea- and tick-control after a single oral dose. Scalibor™ Protectorband (deltamethrin; MSD Animal Health) is a collar often used to reduce sandfly feeding for leishmaniasis prevention. This study investigated the safety of the concurrent use of BravectoTM and ScaliborTM Protectorband at the recommended dosage regimens. Findings. Throughout the study period of 24 weeks, there were no clinical findings related to the concurrent treatment with Bravecto™ in dogs fitted with Scalibor™ Protectorband at the recommended dosage regimen. Conclusions: Concurrent treatment with Bravecto™ in dogs fitted with Scalibor™ Protectorband is well tolerated. © 2014 Walther et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Walther, F. M., Fisara, P., Allan, M. J., Roepke, R. K. A., & Nuernberger, M. C. (2014). Safety of the concurrent treatment of dogs with BravectoTM (fluralaner) and ScaliborTM protectorband (deltamethrin). Parasites and Vectors, 7(1). https://doi.org/10.1186/1756-3305-7-105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free